Anna Migdalska‐Richards

Epigenetic studies of schizophrenia: current status and future directions

J. Mill, A. Migdalska‐Richards, Anna Migdalska‐Richards, 2019, Current Opinion in Behavioral Sciences.

L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils

A. Schapira, M. Spillantini, A. Migdalska‐Richards, 2020, PloS one.

The relationship between glucocerebrosidase mutations and Parkinson disease

A. Schapira, A. Migdalska‐Richards, Anna Migdalska‐Richards, 2016, Journal of neurochemistry.

The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice

A. Schapira, D. D. Di Monte, M. Spillantini, 2017, Brain : a journal of neurology.

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease

A. Schapira, M. Doherty, J. Magalhães, 2016, Human molecular genetics.

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate

W. Ko, Qin Li, E. Bézard, 2017, Synapse.

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice

E. Bézard, A. Schapira, A. Migdalska‐Richards, 2016, Annals of neurology.

DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson’s Individuals with GBA1 Mutations

K. Lunnon, A. Schapira, A. Migdalska‐Richards, 2023, International journal of molecular sciences.

Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons

A. Schapira, J. Magalhães, M. Gegg, 2018, Scientific Reports.